Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20010036464 A1
Publication typeApplication
Application numberUS 09/160,618
Publication dateNov 1, 2001
Filing dateSep 24, 1998
Priority dateSep 24, 1998
Also published asCA2344678A1, CA2344678C, EP1115377A1, EP1115377A4, US6387381, USRE41108, USRE43582, WO2000016743A1
Publication number09160618, 160618, US 2001/0036464 A1, US 2001/036464 A1, US 20010036464 A1, US 20010036464A1, US 2001036464 A1, US 2001036464A1, US-A1-20010036464, US-A1-2001036464, US2001/0036464A1, US2001/036464A1, US20010036464 A1, US20010036464A1, US2001036464 A1, US2001036464A1
InventorsEdwin H. Christensen
Original AssigneeEdwin H. Christensen
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Semi-moist oral delivery system
US 20010036464 A1
Abstract
These and other objects are attained by the subject invention wherein there is provided a carrier or product formed of a matrix having starch, sugar, fat, polyhydric alcohol and water in suitable ratios such that there exists a water activity of 0.6-0.75. The water activity of the product matrix is adjusted up or down so that the availability of water in the finished product is not detrimental to the included active ingredient, be it pharmaceutical, nutraceutical, or a vitamin mineral complex.
Images(5)
Previous page
Next page
Claims(23)
What is claimed is:
1. A carrier for the oral administration of an active ingredient to mammals comprising:
10-50% starch,
0-40% fat or oil,
8-50% polyhydric alcohol,
5-25% sugar
5-20% water, and
1-5% salt
said carrier having an Aw of about 0.60 to 0.75.
2. The carrier of
claim 1
wherein the water content is about 10%.
3. The carrier of
claim 1
wherein the polyhydric alcohol content is about 40%.
4. The carrier of
claim 1
wherein the starch content is about 32%.
5. The carrier of
claim 1
wherein the pregelatinized starch content is about 15%
6. The carrier of
claim 1
wherein the active ingredient is a pharmaceutical.
7. The carrier of
claim 1
wherein the active ingredient is a nutraceutical.
8. The carrier of
claim 1
wherein the active ingredient is a vitamin and mineral mix.
9. The carrier of
claim 1
where the Aw is 0.65 and the active ingredient is aspirin.
10. The carrier of
claim 1
wherein the polyhydric alcohol is sorbitol.
11. The carrier of
claim 1
wherein the sugar content is about 15%.
12. A method of making a carrier for an active ingredient for use in an oral administration of the active ingredient, comprising the steps of:
a) forming a matrix by mixing
10-50% starch,
0-40% fat or oil,
10-50% polyhydric alcohol,
5-25% sugar,
5-20% water, and
1-5% salt
b) adjusting the relative amounts of polyhydric alcohol and water to control the Aw of said carrier;
whereby the controlled Aw permits the moisture in the carrier to be at a level not inimical to the active ingredient.
13. The method of
claim 10
including adjusting the water content to about 10%.
14. The method of
claim 10
including adjusting the polyhydric alcohol content to about 40%.
15. The method of
claim 10
including adjusting the starch content to about 32%.
16. The method of
claim 10
including adjusting the sugar content to about 15%.
17. The method of
claim 10
including adjusting the pregelatinized starch content is about 15%.
18. The method of
claim 10
including the step of mixing in a pharmaceutical.
19. The method of
claim 10
including the step of mixing in a nutraceutical.
20. The method of
claim 10
including the step of mixing in a vitamin and mineral mix.
21. The method of
claim 10
including the step of adding sorbitol.
22. The method of
claim 10
including the step of controlling the Aw to be at about 0.60 to about 0.75.
23. The method of
claim 10
including the step of adding aspirin as the active ingredient and controlling the Aw of said carrier to about 0.65.
Description
    FIELD OF THE INVENTION
  • [0001]
    This application is directed to a means for delivering pharmaceuticals, nutraceuticals and the like to a mammal and more specifically, the control of the water activity of a food product matrix for use in the incorporation of a pharmaceutical, nutraceutical or other bioactive compound into the matrix.
  • BACKGROUND OF THE INVENTION
  • [0002]
    Pharmaceutical and nutraceutical products intended for oral administration are typically provided in tablet, capsule, pill, lozenges and caplet form. These products are swallowed whole or chewed in the mouth for delivery of the active ingredient into the alimentary system of a body. Such oral delivery systems are sometimes made chewable to ease drug administration in pediatric and geriatric patients. Such concerns with ease of administration may be amplified when dealing with pets and other animals.
  • [0003]
    As a result, several approaches have been utilized in formulating oral delivery systems, including gums and candy bases. The use of such delivery systems is limited by the reaction of the active ingredient, whether it be pharmaceutical, nutraceutical or other ingredients, to the existence of water in the system.
  • SUMMARY OF THE INVENTION
  • [0004]
    Therefore, an object of the subject invention is a method of controlling water activity in an oral delivery system and the product thereof.
  • [0005]
    A further object of the subject invention is a oral delivery system for pharmaceuticals, nutraceuticals or other active ingredient which matches the water activity of the carrier to the included active ingredient.
  • DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • [0006]
    By the subject invention, a soft chewable oral delivery system is provided. The dosage form may be in tablet form and may contain one or more active ingredients. The active ingredients are incorporated into the system which is described in further detail below and which includes a starch component, a fat or oil, a sugar component, a polyhydric alcohol, water and other minor ingredients. Into this mixture is placed the active ingredient. After mixing and extruding these ingredients, the extrudate is formed into the appropriate shape. The relative proportions of the mixture are as follows.
    Starch 10-50%
    Fat or Oil 0-40%
    Sugar 5-25%
    Polyhydric Alcohol 10-50%
    Water 5-20%
    Salt (NaCl) 1-5%
    Active Ingredient 0.1-5%
  • [0007]
    Generally speaking, the starch component of the matrix comprises 10 to 50 percent by weight of the matrix. More particularly, the starch component of the matrix comprises 15 to 40 percent by weight of the matrix.
  • [0008]
    While starch for use in the matrix can be of any suitable type, it is most preferred that at least part of the starch in the matrix be a highly derivatized or pregelatinized starch. If a highly derivatized starch is present in the matrix, it should be present in an amount of about percent by weight of the total starch and the balance of the starch being non-derivatized. More preferably, about 20-40 percent by weight of the total matrix and about 45% of the total starch should be the derivatized starch. An example of a preferred pregelatinized starch is A. E. Staley's NU-COL 4227 or SOFT-SET.
  • [0009]
    Other amylaceous ingredients may be used in combination with the derivatized starch or alone, provided the starch limits are not exceeded. The amylaceous ingredients can be gelatinized or cooked before or during the forming step to achieve the desired matrix characteristics. If gelatinized starch is used, it may be possible to prepare the product of the subject invention or perform the method of the subject invention without heating or cooking of any sort. However, if ungelatinized (ungelled) or uncooked starch is used, the matrix must be cooked sufficiently to gel or cook the starch to reach the desired content.
  • [0010]
    Starches that can serve as a base starch for derivatization include regular corn, waxy corn, potato, tapioca, rice, etc. Such types of derivatizing agents for the starch include but are not limited to ethylene oxide, propylene oxide, acetic anhydride, and succinic anhydride, and other food approved esters or ethers, introducing such chemicals alone or in combination with one another. Prior crosslinking of the starch may or may not be necessary based on the pH of the system and the temperature used to form the product.
  • [0011]
    By “amylaceous ingredients” is meant those food-stuffs containing a preponderance of starch and/or starch-like material. Examples of amylaceous ingredients are cereal grains and meals or flours obtained upon grinding cereal grains such as corn, oats, wheat, milo, barley, rice, and the various milling by-products of these cereal grains such as wheat feed flour, wheat middlings, mixed feed, wheat shorts, wheat red dog, oat groats, hominy feed, and other such material. Also included as sources of amylaceous ingredients are the tuberous food stuffs such as potatoes, tapioca, and the like.
  • [0012]
    Another component of the matrix is a fat component such as fat or oil of animal or vegetable origin. Typical animal fats or oils are fish oil, chicken fat, tallow, choice white grease, prime steam lard and mixtures thereof. Other animal fats are also suitable for use in the matrix. Vegetable fats or oils are derived from corn, soy, cottonseed, peanut, flax, rapeseed, sunflower, other oil bearing vegetable seeds, and mixtures thereof. Additionally, a mixture of animal or vegetable oils or fats is suitable for use in the matrix. The fat component of the matrix is about 0 to about 40% by weight of the matrix. More specifically, the fat component of the matrix is about 20 percent by weight of the matrix.
  • [0013]
    The polyhydric alcohol component of the matrix can be selected from glycerol, sorbitol, propylene glycol, 1.3-butanediol, and mixtures thereof with each other and other polyhydric alcohols. Generally the polyhydric alcohol comprises about 10 to about 50 percent by weight of the matrix. More specifically, the polyhydric alcohol comprises about 20 to about 40 percent by weight of the matrix.
  • [0014]
    The sugar component can be employed in a dry or crystalline condition or can be an aqueous syrup having a sugar concentration of from 50 to about 95, preferably from 70 to about 80, weight percent. The sugar used can be lactose, sucrose, fructose, glucose, or maltose, depending on the particular application and price or availability of a particular sugar. Examples of various well established sources of these sugars are, corn syrup solids, malt syrup, hydrolyzed corn starch, hydrol (syrup from glucose manufacturing operations), raw and refined cane and beet sugars, etc.
  • [0015]
    Water must be present in the matrix at least about 5 percent by weight of the matrix. More specifically, water is present in the matrix about 5 percent to about 20 percent by weight of the matrix. The matrix thus formed usually has a water activity of 0.60 to 0.75.
  • [0016]
    While water must be at least 5 percent by weight of the matrix, when the matrix is used in a food product, the moisture of the food product must be adjusted. Generally the moisture content of the matrix is such to give a moisture content of 5-15 percent to the final soft dry food product. More preferred is a moisture content of 5 percent to 14 percent. Most preferred is a moisture content of 8 percent to 13 percent. The desired moisture content may be achieved in any suitable fashion. Normal processing may produce the moisture content desired. A standard drying step is optional and may be used if necessary.
  • [0017]
    The active ingredient may be any drug, nutrition agent, or the like which can be orally administered. Exemplary of such active ingredients are the flowing: nutraceuticals, such as chromium picolinate, potassium gluconate and methionine amino acid; prescription drugs, such as ivermectin, fenbendazole, piperazine, magnesium hydroxide, stranozole, furosemide, penicillin, amoxicillin, prednisolone, methylprednisolone, acepromazine; and, other pharmaceutical products, such as aspirin, prozac, zantac, and benedryl. Minor amounts of flavorants, colorants, glycerin, flavor enhancers, sweeteners, emulsifiers, antibitterness agents, taste masking agents, stabilizers, preservatives, or combinations thereof may be added.
  • [0018]
    To form the matrix, the starch system, fat, polyhydric alcohol, corn syrup and water are mixed with a screw extruder, permitting addition of ingredients and variable heating at different points along the barrel. Other mixing apparatus, such as a sigma mixer, swept wall heat exchanger or the like may be used. If a coloration is desired in the final product, cooked or pregelled starches are used to form the matrix. The use of these starches avoids high cooking temperatures which would destroy the desire coloration and/or active ingredient. If coloration active temperature sensitivity is not a problem, it is possible to use an uncooked or ungelatinized starch to form the matrix and cook or gel the starch as the process is carried out. The incorporation of a derivatized starch in the product more clearly guarantees the softness of the product for a longer period of time. Softness is also provided by the fats and oils. In this fashion a suitable matrix is provided for use with a wide variety of active ingredients.
  • [0019]
    Having fully described the invention, the following examples are presented to illustrate the invention without limitation thereof. In these examples all parts percentages are by weight unless otherwise specified.
  • EXAMPLE 1 Carrier
  • [0020]
    [0020]
    INGREDIENT PARTS
    Regular Corn Starch (Purefood GMI) 17.9
    Pregel Starch (SOFT SET) 15.0
    Corn Syrup (Star Dri Corn Syrup Solids) 15.0
    Corn Oil 20.0
    Sorbitol 20.0
    Active 0.1
    H2O 10.0
    Salt 2.0
    TOTAL 100.0
  • [0021]
    The above ingredients are mixed at temperatures of about 125 F., extruded and cut into a suitable tablet size. This product has an oily, bubbly appearance suggesting cutting back on the oil content. Temperature was also adjusted during each of the following examples to eliminate puffing of the product as it exits the extruder.
  • EXAMPLE 2 Guaifenesin
  • [0022]
    [0022]
    INGREDIENT PARTS
    Regular Corn Starch (Purefood GMI) 17.9
    Pregel Starch (SOFT SET) 15.0
    Corn Syrup (Star Dri Corn Syrup Solids) 15.0
    Sorbitol 39.3
    H2O 10.0
    Salt 2.0
    Guaifenesin* 0.8
    TOTAL 100.0
  • EXAMPLE 3 Vitamins
  • [0023]
    [0023]
    INGREDIENT PARTS
    Regular Corn Starch (Purefood GMI) 17.9
    Pregel Starch (SOFT SET) 15.0
    Corn Syrup (Star Dri Corn Syrup Solids) 15.0
    Sorbitol 35.1
    H2O 10.0
    Salt 2.0
    Vitamin and Mineral Mix* 5.0
    TOTAL 100.0
  • EXAMPLE 4 Flax
  • [0024]
    [0024]
    INGREDIENT PARTS
    Regular Corn Starch (Purefood GMI) 17.9
    Pregel Starch (SOFT SET) 15.0
    Corn Syrup (Star Dri Corn Syrup Solids) 15.0
    Sorbitol 35.1
    H2O 10.0
    Salt 2.0
    Flax* 5.0
    TOTAL 100.0
  • EXAMPLE 5 Acetaminophen
  • [0025]
    [0025]
    INGREDIENT PARTS
    Regular Corn Starch (Purefood GMI) 17.9
    Pregel Starch (SOFT SET) 15.0
    Corn Syrup (Star Dri Corn Syrup Solids) 15.0
    Sorbitol 39.1
    H2O 10.0
    Salt 2.0
    Acetaminophen* 0.8
    Red Coloring #40 0.1
    Flavoring (Cherry) 0.1
    TOTAL 100.0
  • EXAMPLE 6 Carrier
  • [0026]
    [0026]
    INGREDIENT PARTS
    Regular Corn Starch (Purefood GMI) 17.9
    Pregel Starch (SOFT SET) 15.0
    Corn Syrup (Star Dri Corn Syrup Solids) 15.0
    Sorbitol 40.1
    H2O 10.0
    Salt 2.0
    TOTAL 100.0
  • [0027]
    [0027]
    TABLE 1
    Example Active Oil/Sugar AW Extrusion Temp.
    1 Premix Corn Oil/Sorbitol N/A 125
    2 Guaifenesin 100% Sorbitol 0.656 115
    3 Vitamin Mix 100% Sorbitol 0.651 115
    4 Flax 100% Sorbitol 0.673 115
    5 Acetaminophen 100% Sorbitol 0.666 115
    6 Premix 100% Sorbitol 0.61  115
  • [0028]
    By the above examples and Table 1 it is apparent that an oral delivery system for the administration for pharmaceuticals, nutraceuticals, vitamins and minerals and other active ingredients may be provided in a chewable form by the subject invention. If the active ingredient is water sensitive such as aspirin, then the amount of polyhydric alcohol is increased, the water activity is depressed to about 0.65 and the stability and texture of the resultant product is maintained. If the active ingredient requires or can tolerate the presence of free water for its activity, such as in the case of Guaifenesin, the amount of polyhydric alcohol may be decreased, while maintaining the level of such polyhydric alcohol such that a soft texture of the resulting tablet is maintained. In the case of Guaifenesin, then an Aw of 0.70 may be utilized and a softer, more chewable texture achieved. An effective oral delivery system in which the texture and stability of the product and activity of the active ingredient is controllable, is the result.
  • [0029]
    While the invention has been described with reference to a preferred embodiment, it will be understood by those skilled in the art that various changes may be made and equivalents may be substituted for elements thereof without departing from the scope of the invention. In addition, many modifications may be made to adapt a particular situation or material to the teachings of the invention without departing from the essential scope thereof. Therefore, it is intended that the invention not be limited to the particular embodiment disclosed as the best mode contemplated for carrying out this invention, but that the invention will include all embodiments and equivalents falling within the scope of the appended claims.
  • [0030]
    Various features of the invention are set forth in the following claims.
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7067150Mar 25, 2003Jun 27, 2006Scepter Holdings, Inc.Delivery systems for functional ingredients
US7531192Apr 21, 2005May 12, 20092120812 Ontario Inc.Delivery systems for functional ingredients
US7727546Jul 7, 2006Jun 1, 2010Micro Nutrient, LlcNutrient system for individualized responsive dosing regimens
US7785619Aug 31, 2010Micro Nutrient, LlcPharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
US7850987Dec 14, 2010Micronutrient, LlcNutrient composition(s) and system(s) for individualized, responsive dosing regimens
US8541019Oct 31, 2011Sep 24, 2013Novartis AgPalatable ductile chewable veterinary composition
US8628794Jul 29, 2004Jan 14, 2014Novartis AgPalatable ductile chewable veterinary composition
US9233100Jan 31, 2013Jan 12, 2016Merial, Inc.Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
US9259417Feb 20, 2015Feb 16, 2016Merial, Inc.Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
US20040237663 *Mar 25, 2003Dec 2, 2004Michael FarberDelivery systems for functional ingredients
US20050226907 *Mar 15, 2005Oct 13, 2005Moneymaker Ricky DPharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
US20060141009 *Aug 13, 2003Jun 29, 2006Sebastien HuronNovel compositions and processes for delivering an additive
US20060222684 *Jul 29, 2004Oct 5, 2006Ute IselePalatable ductile chewable veterinary composition
US20060269619 *Jul 7, 2006Nov 30, 2006Micro Nutrient, LlcNutrient system for individualized responsive dosing regimens
US20080193602 *Feb 19, 2008Aug 14, 2008Ricky Dean MoneymakerNutrient Composition(s) and System(s) for Individualized, Responsive Dosing Regimens
US20090054536 *Feb 5, 2007Feb 26, 2009Vetinnovpalatable support of improved formula
US20100047223 *Oct 27, 2009Feb 25, 2010Ricky Dean MoneymakerPharmanutrient Composition(s) and System(s) for Individualized, Responsive Dosing Regimens
US20100047364 *Oct 27, 2009Feb 25, 2010Moneymaker Ricky DNutrient System for Individualized Responsive Dosing Regimens
WO2005102295A1 *Mar 15, 2005Nov 3, 2005Micro Nutrient, LlcPharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
WO2007090987A2 *Feb 5, 2007Aug 16, 2007VetinnovPalatable support with an improved formula
WO2007090987A3 *Feb 5, 2007Nov 1, 2007VetinnovPalatable support with an improved formula
WO2013037650A1Aug 31, 2012Mar 21, 2013Friulchem SpaCompositions for oral administration to animals, production methods thereof and uses of same
WO2014033230A1Aug 29, 2013Mar 6, 2014Friulchem SpaCompositions for oral administration to animals, production methods thereof and uses of same
Classifications
U.S. Classification424/400
International ClassificationA61K9/00
Cooperative ClassificationA61K9/0056
European ClassificationA61K9/00M18B
Legal Events
DateCodeEventDescription
Oct 26, 1998ASAssignment
Owner name: VETHEALTH, INC., FLORIDA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CHRISTENSEN, EDWIN H.;REEL/FRAME:009548/0997
Effective date: 19981009
Nov 10, 1998ASAssignment
Owner name: AMT CAPITAL, LTD., FLORIDA
Free format text: SECURITY INTEREST;ASSIGNOR:DRUG DELIVERY SYSTEMS, INC.;REEL/FRAME:009786/0185
Effective date: 19981027
Owner name: DRUG DELIVERY SYSTEMS, INC., FLORIDA
Free format text: CHANGE OF NAME;ASSIGNOR:VETHEALTH, INC.;REEL/FRAME:009613/0560
Effective date: 19981027
Mar 12, 2002ASAssignment
Owner name: DRUG DELIVERY SYSTEMS, INC., FLORIDA
Free format text: CHANGE OF NAME;ASSIGNOR:VETHEATH, INC.;REEL/FRAME:012693/0072
Effective date: 19981027
Owner name: EZ-MED COMPANY, FLORIDA
Free format text: CHANGE OF NAME;ASSIGNOR:DRUG DELIVERY SYSTEMS, INC.;REEL/FRAME:012980/0417
Effective date: 20011207
Jun 12, 2002ASAssignment
Owner name: DRUG DELIVERY SYSTEMS, INC., FLORIDA
Free format text: CHANGE OF NAME;ASSIGNOR:VET HEALTH, INC.;REEL/FRAME:012979/0656
Effective date: 19981027
Oct 31, 2002ASAssignment
Owner name: EZ-MED COMPANY, FLORIDA
Free format text: CHANGE OF NAME;ASSIGNOR:DRUG DELIVERY SYSTEMS, INC.;REEL/FRAME:013438/0817
Effective date: 20011206
Apr 27, 2004RFReissue application filed
Effective date: 20030813
May 19, 2005FPAYFee payment
Year of fee payment: 4
Jun 2, 2009RFReissue application filed
Effective date: 20090429
Sep 29, 2009RFReissue application filed
Effective date: 20090429
Dec 21, 2009REMIMaintenance fee reminder mailed
Sep 24, 2010ASAssignment
Owner name: EZ-MED HOLDINGS, INC., FLORIDA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:EZ-MED COMPANY;REEL/FRAME:025039/0010
Effective date: 20100820
May 21, 2012ASAssignment
Owner name: FLAVORTEK, LLC, FLORIDA
Free format text: SECURITY AGREEMENT;ASSIGNOR:EZ-MED HOLDINGS, INC.;REEL/FRAME:028244/0568
Effective date: 20120419
Owner name: LEHMKUHL, ALFRED, OHIO
Free format text: SECURITY AGREEMENT;ASSIGNOR:EZ-MED HOLDINGS, INC.;REEL/FRAME:028244/0568
Effective date: 20120419
Jun 25, 2014ASAssignment
Owner name: EZ-MED HOLDINGS, INC., FLORIDA
Free format text: TERMINATION OF SECURITY INTEREST;ASSIGNORS:FLAVORTEK, LLC;LEHMKUHL, ALFRED;REEL/FRAME:033227/0306
Effective date: 20140414